Elanco Animal Health Incorporated
ELAN
$21.43
-$0.29-1.34%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 10.53% | 6.22% | 3.08% | -0.18% | 1.42% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.53% | 6.22% | 3.08% | -0.18% | 1.42% |
| Cost of Revenue | 10.12% | 5.94% | 2.48% | 0.84% | 2.31% |
| Gross Profit | 10.86% | 6.44% | 3.57% | -1.01% | 0.70% |
| SG&A Expenses | 11.51% | 8.79% | 6.53% | 5.19% | 1.71% |
| Depreciation & Amortization | 5.94% | 3.04% | -0.19% | -2.77% | -4.57% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.66% | 6.55% | 3.53% | 1.96% | 1.46% |
| Operating Income | 25.31% | 0.78% | -4.26% | -29.51% | 0.82% |
| Income Before Tax | -136.75% | -145.90% | -103.88% | 147.67% | 141.52% |
| Income Tax Expenses | -72.39% | -94.67% | -125.12% | 1,345.45% | 1,381.82% |
| Earnings from Continuing Operations | -164.88% | -168.64% | -82.44% | 134.58% | 128.65% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -164.88% | -168.64% | -82.44% | 134.58% | 128.65% |
| EBIT | 25.31% | 0.78% | -4.26% | -29.51% | 0.82% |
| EBITDA | 12.40% | 3.30% | 4.63% | -6.76% | -0.35% |
| EPS Basic | -164.58% | -168.18% | -82.39% | 134.46% | 128.54% |
| Normalized Basic EPS | 292.52% | 435.90% | 192.44% | 55.70% | 119.04% |
| EPS Diluted | -167.68% | -171.77% | -84.83% | 133.66% | 127.84% |
| Normalized Diluted EPS | 285.38% | 417.72% | 190.69% | 54.25% | 118.79% |
| Average Basic Shares Outstanding | 0.51% | 0.47% | 0.43% | 0.38% | 0.34% |
| Average Diluted Shares Outstanding | 0.73% | 0.53% | 0.49% | 0.79% | 0.57% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |